NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

GENOMIC VALLEY BIOTECH

BSE: 539206 22 Feb 2025
Healthcare
₹ 61.0
GENOMIC VALLEY BIOTECH LIMITED specializes in Biotechnology within the Healthcare sector.

GENOMIC VALLEY BIOTECH - Share Price & Details

Market Cap
₹18.6
High /Low
108.0 / 28.4
Stock P/E
46.6
Book Value
₹12.5
Dividend Yield
0.0
ROCE
0.57
ROE
₹0.57
Face Value
10.0
PEG Ratio
-1.2
EVEBITDA
₹45.5
Debt
0.00
CMP / FCF
14.5
Debt to equity
₹0.0
NP Ann
0.02
High price all time
108.0
Piotroski score
₹4.0
Graham Number
19.2
No. Eq. Shares
0.31
Net CF
₹-0.04
Net profit
0.40
Price to book value
4.89
Interest Coverage
₹NA
Low price all time
8.25
Industry PE
27.3
Reserves
₹0.76
Free Cash Flow
₹-0.02

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
GENOMIC VALLEY BIOTECH LIMITED2.200.5146.6
Span Divergent Limited18.96-0.3912.2
Parmax Pharma Limited62.84NA

Peer Comparison Chart


About GENOMIC VALLEY BIOTECH

GENOMIC VALLEY BIOTECH LIMITED, with Security Code 539206, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

(14 Dec 2024)
Genomic Valley Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2024.
Read more →

Genomic Valley Standalone September 2024 Net Sales at Rs 0.21 crore, up 203.61% Y-o-Y

(21 Oct 2024)
Quarterly Net Profit at Rs. 0.15 crore in September 2024 up 535.78% from Rs. 0.02 crore in September 2023.
Read more →

Genomic Valley Biotech standalone net profit rises 650.00% i

(09 Oct 2024)
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter...
Read more →

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

(08 Oct 2024)
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter...
Read more →

RateGain announces extended collaboration with FlyArystan

(08 Oct 2024)
FlyArystan, Kazakhstan's premier low-cost airline and a subsidiary of the Air Astana group, has extended its partnership with AirGain.
Read more →

Lemon Tree Hotels signs a new property in Udaipur

(08 Oct 2024)
Lemon Tree Hotels announced that it has signed a license agreement viz Lemon Tree Hotel in Udaipur, Rajasthan.
Read more →